Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer Patients



Status:Completed
Conditions:Lung Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:4/2/2016
Start Date:February 2007
End Date:July 2014

Use our guide to learn which trials are right for you!

Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer Patients (Old Title: Significance of CD44 and or Epithelial Specific Antigen Positive Cells in the Peripheral Blood of Lung Cancer Patients) (LUN0017)

The primary aim of this study is to determine whether we can identify human lung cancer
tumor cells in the peripheral blood of lung cancer patients.

The purpose of this study is to determine whether we can identify lung cancer cells
circulating in the peripheral blood of lung cancer patients using cell surface markers found
on cancer cells such as CD44 and epithelial specific antigen.

Inclusion Criteria:Inclusion Criteria:Inclusion Criteria (Cases):

1. Advanced stage (IIIB with malignant effusion or IV) histologically or cytologically
confirmed NSCLC

2. Patients must be newly diagnosed (untreated) or have evidence of disease progression
at the time of sample collection

3. ability to sign informed consent

4. at least 18 years of age

Inclusion Criteria (Controls):

1. no known prior or active malignancy

2. ability to sign informed consent

3. at least 18 years of age Exclusion Criteria:1. history of any other cancer other than
non-melanoma skin cancer within the last 5 years

Exclusion Criteria:1. history of any other cancer other than non-melanoma skin cancer
within the last 5 years

2. pregnant women
We found this trial at
1
site
291 Campus Dr
Stanford, California 94305
(650) 725-3900
Stanford University School of Medicine Vast in both its physical scale and its impact on...
?
mi
from
Stanford, CA
Click here to add this to my saved trials